1 Min Read
May 17 (Reuters) - Merck & Co Inc:
* Merck’s Glucophage SR receives label extension for patients at high risk of type 2 diabetes in the UK Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.